Gilead Research Funding Programs
Service by Gilead Sciences
Advancing scientific discovery through external research support and community partnerships.
These programs advance scientific understanding in virology, oncology, and inflammation while supporting emerging investigators and community-led health initiatives.
- Languages
- English
Category: Clinical Trials
- Support Types
- Funding, Study Drug, Technical Support
- Submission Methods
- RFP, Letter of Interest
- Therapeutic Areas
- Virology, Oncology, Inflammation, Liver Disease
- Program Launch Year
- 2008 (Research Scholars Program)
- Supports third-party research on Gilead products and therapeutic areas
- Research Scholars Program supports emerging investigators since 2008
Overview
The Research Scholars Program, launched in 2008, specifically supports emerging investigators to address knowledge gaps and drive medical breakthroughs. These programs are designed to supplement registration studies with real-world safety and efficacy data while fostering diverse scientific perspectives.
Externally Sponsored Research
- Third-Party Product Research: Gilead supports research conducted by third parties on its products or within its therapeutic areas of interest.
- RFP Application Process: Researchers can apply through specific Request for Proposal (RFP) programs or RFP Topics of Interest focused on specific populations.
- Letter of Interest Submissions: Investigators have the option to submit their own research concepts via a Letter of Interest for consideration.
Research Scholars Program
- Emerging Investigator Support: The program supports meaningful research by high-caliber, emerging investigators to address knowledge gaps and drive breakthroughs.
- Oncology Research Focus: The program supports independent research in oncology to incorporate new perspectives in scientific understanding.
- Liver Disease Research Focus: Support is available for research projects focused on liver disease to advance knowledge in areas of unmet medical need.
Community-Based Participatory Research
- Health Outcomes Focus: Support is aimed at improving health outcomes and quality of care in populations of need.
What's included
- Externally Sponsored Research, Research Scholars Program, Community-Based Participatory Research
How it works
- Identify RFP opportunity or Topic of Interest, Submit Letter of Interest or RFP application, Review by Gilead, Award of funding or study drug support
Use cases
- Emerging investigators apply for the Research Scholars Program to fund breakthroughs in HIV or oncology research.
- Scientific investigators submit Letters of Interest to propose new research concepts within Gilead's therapeutic areas.
Specifications
- How to get it
- Online via RFP applications or Letter of Interest submissions
- Support Types
- Funding, Study Drug, Technical Support
- Submission Methods
- RFP, Letter of Interest
- Therapeutic Areas
- Virology, Oncology, Inflammation, Liver Disease
- Program Launch Year
- 2008 (Research Scholars Program)
How it works
- Identify Opportunities: Investigators identify relevant Request for Proposal (RFP) programs or RFP Topics of Interest on the Gilead website.
- Submit Application: Researchers submit their research concepts through a Letter of Interest or a formal RFP application.
- Review and Approval: Gilead reviews the submissions for scientific merit and alignment with therapeutic areas of interest.
- Receive Support: Approved projects receive financial funding, study drugs, or other forms of support to conduct their independent research.
FAQ
What therapeutic areas does the Research Scholars Program cover?
The program supports emerging investigators in therapeutic areas including HIV, Viral Hepatitis, Oncology, and Liver Disease.
Added by AntSpace from public sources (gilead.com).